Artemis Medicare Services Ltd has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.130.55 crores during the period ended March 31, 2021 as compared to Rs.124.87 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.12.65 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.5.25 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.9.59 for the period ended March 31, 2021 as compared to Rs.4.03 for the period ended December 31, 2020.
|
Total Income | ₹ 130.55 crs | ₹ 124.87 crs | 4.55% |
Net Profit | ₹ 12.65 crs | ₹ 5.25 crs | 140.95% |
EPS | ₹ 9.59 | ₹ 4.03 | 137.97% |
Financial Results (Q4 FY20-21) - YoY ComparisonThe company has reported total income of Rs.130.55 crores during the period ended March 31, 2021 as compared to Rs.140.52 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.12.65 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.4.22 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.9.59 for the period ended March 31, 2021 as compared to Rs.3.26 for the period ended March 31, 2020.
|
Total Income | ₹ 130.55 crs | ₹ 140.52 crs | -7.1% |
Net Profit | ₹ 12.65 crs | ₹ 4.22 crs | 199.76% |
EPS | ₹ 9.59 | ₹ 3.26 | 194.17% |
Financial Results (Year ended FY 20-21) - YoY ComparisonThe company has reported total income of Rs.411.94 crores during the 12 months period ended March 31, 2021 as compared to Rs.569.61 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.6.16 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.19.46 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.4.90 for the 12 months period ended March 31, 2021 as compared to Rs.14.95 for the 12 months period ended March 31, 2020.
|
Total Income | ₹ 411.94 crs | ₹ 569.61 crs | -27.68% |
Net Profit | ₹ 6.16 crs | ₹ 19.46 crs | -68.35% |
EPS | ₹ 4.90 | ₹14.95 | -67.22% |
Exceptional item consist of reversal of old disputed liability of Rs. 323.29 lacs carried forward from Artemis Global Life Sciences Limited (AGLSL) (the erstwhile ultimate parent company of Artemis Medicare Services Limited) prior to the merger which was under Arbitration. The Management has been advised by an independent legal expert that since the Arbitration proceedings are not being carried out for last many years, this amount is now no longer payable. Accordingly, the same has been written back by the Holding Company.
Shares of Artemis Medicare Services Ltd. was last trading in BSE at Rs. 230.45 as compared to the previous close of Rs. 222.45. The total number of shares traded during the day was 14,795 and the deliverable quantity was 10380 shares.
The stock hit an intraday high of Rs. 237 and intraday low of Rs. 225.15.
Source : Equity Bulls
Keywords